Live Breaking News & Updates on Cellectis Daily|Page 7
Stay updated with breaking news from Cellectis daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Several other brokerages have also recently commented on CLLS. JMP Securities reissued a market outperform rating and set a $6.00 price target on […] ....
StockNews.com started coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a report released on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Other analysts have also recently issued reports about the stock. JMP Securities reaffirmed a market outperform rating and issued a $6.00 price target on shares of Cellectis […] ....
StockNews.com started coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities research analysts have also recently commented on the stock. Bryan, Garnier & Co assumed coverage on shares of Cellectis in a research report […] ....
Analysts at StockNews.com began coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the biotechnology company’s stock. Several other analysts have also weighed in on the company. Oppenheimer lowered their price objective on Cellectis from $16.00 to […] ....
Cellectis S.A. (NASDAQ:CLLS – Free Report)’s share price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $1.90 and traded as low as $1.86. Cellectis shares last traded at $1.95, with a volume of 16,965 shares traded. Analyst Ratings Changes CLLS has been the topic […] ....